HIV seropositive disclosure and associated factors among adult HIV positive clients in public health facilities in East Wollega Zone, Oromia Regional State, Western Ethiopia.

Autor: Fikadu W; Department of Public Health, Institute of Health Science, Wollega University, Nekemt, Ethiopia., Dechassa C; Gida Ayana Public Health Facility, Gida Ayana General Hospital, Ayana, Ethiopia., Desalegn Z; Department of Public Health, Institute of Health Science, Wollega University, Nekemt, Ethiopia., Ewunetu A; Department of Public Health, Institute of Health Science, Wollega University, Nekemt, Ethiopia., Lema M; Department of Public Health, Institute of Health Science, Wollega University, Nekemt, Ethiopia., Tekle A; Department of Public Health, Institute of Health Science, Wollega University, Nekemt, Ethiopia.

Publikováno v: PloS one [PLoS One] 2024 Oct 29; Vol. 19 (10), pp. e0305389. Date of Electronic Publication: 2024 Oct 29 (Print Publication: 2024).

Factors associated with PrEP-era HIV seroconversion in a 4-year U.S. national cohort of n = 6059 sexual and gender minority individuals who have sex with men, 2017-2022.

Autor: Grov C; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.; CUNY Institute for Implementation Science in Population Health, New York City, New York, USA., Guo Y; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.; CUNY Institute for Implementation Science in Population Health, New York City, New York, USA., Westmoreland DA; University of Florida, Gainesville, Florida, USA., D'Angelo AB; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.; CUNY Institute for Implementation Science in Population Health, New York City, New York, USA., Mirzayi C; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.; CUNY Institute for Implementation Science in Population Health, New York City, New York, USA., Dearolf M; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.; CUNY Institute for Implementation Science in Population Health, New York City, New York, USA., Carneiro P; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA., Ray M; University of Memphis, Memphis, Tennessee, USA., Pantalone D; University of Massachusetts Boston, Boston, Massachusetts, USA., Carrico AW; Florida International University, Miami, Florida, USA., Patel VV; Albert Einstein College of Medicine, Bronx, New York, USA., Golub SA; Hunter College of CUNY, New York City, New York, USA., Hirshfield S; State University of New York (SUNY) Downstate, Brooklyn, New York, USA., Hoover DR; Rutgers University, New Brunswick, New Jersey, USA., Nash D; City University of New York (CUNY) Graduate School of Public Health and Health Policy, New York City, New York, USA.; CUNY Institute for Implementation Science in Population Health, New York City, New York, USA.

Publikováno v: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Jun; Vol. 27 (6), pp. e26312.

Nationwide Longitudinal Annual Survey of HIV/AIDS Referral Hospitals in Japan From 1999 to 2021: Trend in Non-AIDS-defining Cancers Among Individuals Infected With HIV-1.

Autor: Tanaka T; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan., Oshima K; Department of Internal Medicine, Nagasaki Goto Chuoh Hospital, Goto-shi, Nagasaki, Japan., Kawano K; Department of Hospital Medicine, Urasoe General Hospital, Urasoe-shi, Okinawa, Japan., Tashiro M; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan.; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Science, Nagasaki-shi, Nagasaki, Japan., Kakiuchi S; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan., Tanaka A; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan., Fujita A; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan., Ashizawa N; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan., Tsukamoto M; Department of Internal Medicine, Zenjinkai Hospital, Miyazaki-shi, Miyazaki, Japan., Yasuoka A; Division of Internal Medicine, Michinoo Hospital, Nagasaki-shi, Nagasaki, Japan ; and., Teruya K; Department of AIDS Clinical Center, Center Hospital of the National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan ., Izumikawa K; Infection Control and Education Center, Nagasaki University Hospital, Nagasaki-shi, Nagasaki, Japan.; Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Science, Nagasaki-shi, Nagasaki, Japan.

Publikováno v: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2024 May 01; Vol. 96 (1), pp. 1-10. Date of Electronic Publication: 2024 Apr 10.

Can laboratory HIV and infectious syphilis data inform future pre-exposure prophylaxis use in women in Ontario, Canada?

Autor: Sadeghi Y; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.; MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada., Nelson P; Public Health Ontario, Toronto, Ontario, Canada., Sullivan A; Public Health Ontario, Toronto, Ontario, Canada., Allen V; Public Health Ontario, Toronto, Ontario, Canada.; Laboratory Medicine and Pathobiology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.; Mount Sinai Hospital, Toronto, ON, Canada.; Division of Infectious Diseases, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada., Hasso M; Public Health Ontario, Toronto, Ontario, Canada., Liu J; Public Health Ontario, Toronto, Ontario, Canada., Tran V; Public Health Ontario, Toronto, Ontario, Canada.; Laboratory Medicine and Pathobiology, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada., Tan DHS; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada darrell.tan@unityhealth.to.; Division of Infectious Diseases, University of Toronto Temerty Faculty of Medicine, Toronto, Ontario, Canada.; Unity Health Toronto, Toronto, Ontario, Canada.; Division of Infectious Diseases, St. Michael's Hospital, Toronto, ON, Canada.

Publikováno v: Sexually transmitted infections [Sex Transm Infect] 2024 Apr 18; Vol. 100 (3), pp. 184-186. Date of Electronic Publication: 2024 Apr 18.

Receptor transfer between immune cells by autoantibody-enhanced, CD32-driven trogocytosis is hijacked by HIV-1 to infect resting CD4 T cells.

Autor: Albanese M; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany; Department for Clinical Sciences and Community Health (DISCCO), University of Milan, Milan, Italy., Chen HR; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany. Electronic address: hong-ru@besson-girard.fr., Gapp M; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Muenchhoff M; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany., Yang HH; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Peterhoff D; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Hoffmann K; Institute of Virology, University Medical Center, Albert-Ludwigs-University Freiburg, Freiburg, Germany., Xiao Q; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Ruhle A; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Ambiel I; Department of Infectious Diseases, Heidelberg University, Medical Faculty Heidelberg, Integrative Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg, Germany; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany., Schneider S; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Mejías-Pérez E; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Stern M; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Wratil PR; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Hofmann K; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Amann L; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Jocham L; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Fuchs T; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany., Ulivi AF; Max Planck Institute of Psychiatry, Munich, Germany., Besson-Girard S; Institute for Stroke and Dementia Research, University Hospital, LMU München, Munich, Germany., Weidlich S; Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Schneider J; Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Spinner CD; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany; Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Department of Internal Medicine II, Munich, Germany., Sutter K; University Hospital Essen, University Duisburg-Essen, Institute for Virology and Institute for Translational HIV Research, Essen, Germany., Dittmer U; University Hospital Essen, University Duisburg-Essen, Institute for Virology and Institute for Translational HIV Research, Essen, Germany., Humpe A; Department of Transfusion Medicine, Cell Therapeutics, and Hemostaseology, Department of Anesthesiology, University Hospital Munich, Munich, Germany., Baumeister P; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital, LMU München, Munich, Germany., Wieser A; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany; Max von Pettenkofer Institute, Medical Microbiology and Hospital Epidemiology, Faculty of Medicine, LMU München, Munich, Germany; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU München, Munich, Germany., Rothenfusser S; Division of Clinical Pharmacology, University Hospital, LMU München and Unit Clinical Pharmacology (EKliP), Helmholtz Center for Environmental Health, Munich, Germany., Bogner J; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany; Division of Infectious Diseases, University Hospital, Medizinische Klinik und Poliklinik IV, LMU München, Munich, Germany., Roider J; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany; Division of Infectious Diseases, University Hospital, Medizinische Klinik und Poliklinik IV, LMU München, Munich, Germany., Knolle P; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany; Institute of Molecular Immunology and Experimental Oncology, School of Medicine, Technical University of Munich (TUM), Munich, Germany., Hengel H; Institute of Virology, University Medical Center, Albert-Ludwigs-University Freiburg, Freiburg, Germany., Wagner R; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, Regensburg, Germany., Laketa V; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany; Department of Infectious Diseases, Heidelberg University, Medical Faculty Heidelberg, Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg, Germany., Fackler OT; Department of Infectious Diseases, Heidelberg University, Medical Faculty Heidelberg, Integrative Virology, Center for Integrative Infectious Disease Research (CIID), Heidelberg, Germany; German Centre for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany. Electronic address: oliver.fackler@med.uni-heidelberg.de., Keppler OT; Max von Pettenkofer Institute and Gene Center, Virology, National Reference Center for Retroviruses, Faculty of Medicine, LMU München, Munich, Germany; German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany. Electronic address: keppler@mvp.lmu.de.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2024 Apr 16; Vol. 5 (4), pp. 101483. Date of Electronic Publication: 2024 Apr 04.